Rabbit Polyclonal TMEM66/SARAF antibody. Suitable for IHC-P, WB, ICC/IF and reacts with Human samples. Cited in 1 publication. Immunogen corresponding to Recombinant Fragment Protein within Human SARAF aa 1-250.
pH: 7
Preservative: 0.01% Thimerosal (merthiolate)
Constituents: 78.99% PBS, 20% Glycerol (glycerin, glycerine), 1% BSA
IHC-P | WB | ICC/IF | |
---|---|---|---|
Human | Tested | Tested | Tested |
Species | Dilution info | Notes |
---|---|---|
Species Human | Dilution info 1/100.00000 - 1/1000.00000 | Notes Perform heat-mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol. |
Species | Dilution info | Notes |
---|---|---|
Species Human | Dilution info 1/500.00000 - 1/3000.00000 | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Human | Dilution info 1/100.00000 - 1/1000.00000 | Notes - |
Negative regulator of store-operated Ca(2+) entry (SOCE) involved in protecting cells from Ca(2+) overfilling. In response to cytosolic Ca(2+) elevation after endoplasmic reticulum Ca(2+) refilling, promotes a slow inactivation of STIM (STIM1 or STIM2)-dependent SOCE activity: possibly act by facilitating the deoligomerization of STIM to efficiently turn off ORAI when the endoplasmic reticulum lumen is filled with the appropriate Ca(2+) levels, and thus preventing the overload of the cell with excessive Ca(2+) ions.
TMEM66, XTP3, HSPC035, NPD003, PSEC0019, UNQ1967/PRO4499, SARAF, Store-operated calcium entry-associated regulatory factor, SOCE-associated regulatory factor, HBV X-transactivated gene 3 protein, HBV XAg-transactivated protein 3, Protein FOAP-7, Transmembrane protein 66
Rabbit Polyclonal TMEM66/SARAF antibody. Suitable for IHC-P, WB, ICC/IF and reacts with Human samples. Cited in 1 publication. Immunogen corresponding to Recombinant Fragment Protein within Human SARAF aa 1-250.
pH: 7
Preservative: 0.01% Thimerosal (merthiolate)
Constituents: 78.99% PBS, 20% Glycerol (glycerin, glycerine), 1% BSA
TMEM66 also known as SARAF acts as a negative regulator of store-operated calcium entry (SOCE). It plays a role in maintaining cellular calcium homeostasis by limiting calcium influx. TMEM66 has a mass of approximately 36 kDa and is encoded by the SARAF gene. It is primarily expressed in the endoplasmic reticulum membrane but can also localize to the plasma membrane depending on the cellular context. It mainly appears in tissues with high metabolic or excitatory activity like the brain and heart.
TMEM66/SARAF functions to prevent calcium overload in cells by interacting with the calcium release-activated calcium (CRAC) channel components. It acts as a part of the larger store-operated calcium channel complex which includes STIM1 and Orai1. The interaction of TMEM66 with these proteins modulates their activity and ensures a controlled calcium entry into the cell playing a protective role during stimulations that otherwise might cause cellular damage due to excessive calcium levels.
TMEM66/SARAF directly influences the calcium signaling pathway and is also indirectly involved in the MAPK/ERK pathway. Calcium signaling is essential for various cellular processes including muscle contraction neurotransmitter release and gene expression. TMEM66 regulates this pathway by modulating Orai1 activity which is a critical component of the calcium influx mechanism. The MAPK/ERK pathway associated with cell proliferation and differentiation also interacts with calcium levels bridging a connection to TMEM66's role in cellular responses.
Research links TMEM66/SARAF to cardiac hypertrophy and neurodegenerative diseases. Abnormalities in calcium homeostasis influenced by TMEM66 can lead to pathologies like excess growth of heart muscle cells (cardiac hypertrophy). Additionally disrupted calcium signaling related to TMEM66's dysregulation potentially contributes to neuronal damage seen in neurodegenerative conditions. The protein's interaction with STIM1 and Orai1 underlies these disease connections as disturbances in these proteins' functions can disrupt normal calcium homeostasis potentially leading to cell injury or death.
We have tested this species and application combination and it works. It is covered by our product promise.
We have not tested this specific species and application combination in-house, but expect it will work. It is covered by our product promise.
This species and application combination has not been tested, but we predict it will work based on strong homology. However, this combination is not covered by our product promise.
We do not recommend this combination. It is not covered by our product promise.
We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.
In the unlikely event of one of our products not working as expected, you are covered by our product promise.
Full details and terms and conditions can be found here:
Terms & Conditions.
All lanes: Western blot - Anti-TMEM66/SARAF antibody (ab154538) at 1/1000 dilution
All lanes: Jurkat whole cell lysate at 30 µg
Predicted band size: 37 kDa
Immunohistochemical analysis of paraffin-embedded Human hepatoma tissue labeling TMEM66/SARAF with ab154538 at 1/500 dilution.
Immunofluorescent analysis of methanol-fixed HeLa cells labeling TMEM66/SARAF with ab154538 at 1/500 dilution. Lower panel co-stained with Hoechst 33342.
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com